Health Canada drug identification number

DIN 02466783 — ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS 100 MG; 250 MG

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS is a tablet of Atovaquone / Proguanil marketed by GLENMARK PHARMACEUTICALS CANADA INC.. The full Atovaquone / Proguanil monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02466783
Brand name
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS
Active ingredient
Atovaquone / Proguanil
Strength
100 MG; 250 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
GLENMARK PHARMACEUTICALS CANADA INC.
Health Canada status
MARKETED
Drug class
Antimalarial agent (hydroxynaphthoquinone / biguanide combination)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Atovaquone / Proguanil products

DINBrandStrengthFormManufacturerStatus
02421429 ATOVAQUONE PROGUANIL 100 MG; 250 MG TABLET SANIS HEALTH INC MARKETED
02238151 MALARONE 100 MG; 250 MG TABLET GLAXOSMITHKLINE INC MARKETED
02264935 MALARONE PEDIATRIC 25.0 MG; 62.5 MG TABLET GLAXOSMITHKLINE INC MARKETED
02402165 MYLAN-ATOVAQUONE/PROGUANIL 100 MG; 250 MG TABLET MYLAN PHARMACEUTICALS ULC MARKETED
02380927 TEVA-ATOVAQUONE PROGUANIL 100 MG; 250 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.